corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

All items in the Healthy Skepticism Library

All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.

Page 203 of 206 pages ‹ First  < 201 202 203 204 205 >  Last ›

HSL2719
Pharmaceutical advertising
Rx Bulletin 1970;1:(10):39

HSL2720
You and the ads
Canadian Medical Association Journal 1970;103:329

HSL2721
Eade N.
Readers write about the Journal
Canadian Medical Association Journal 1970;103:184

HSL2722
Jackson N.
Readers write about the Journal
Canadian Medical Association Journal 1970;130:183-184

HSL2723
Mizgala HF, Meldrum DA.
Readers write about the journal
Canadian Medical Association Journal 1970;102:1308

HSL2746
Raine RJ.
Readers write about the Journal
Canadian Medical Association Journal 1970;103:183

HSL2748
Steinmetz N.
Readers write about the Journal
Canadian Medical Association Journal 1970;103:182

HSL2749
Stratford JG.
Readers write about the Journal
Canadian Medical Association Journal 1970;103:183

HSL2750
Tetz WC.
Readers write about the Journal
Canadian Medical Association Journal 1970;103:183

HSL2751
Wilson R.
Readers write about the Journal
Canadian Medical Association Journal 1970;103:184

HSL2755
Barnhart , R .
The medical profession-drug industry alliance
New Physician 1970;20:164-171

HSL8909
Paulshock BZ.
Generic prescription
J Am Med Assoc 1969 Oct 27;210:728

HSL18636
Mendelson H.
Which Shall It Be: Mass Education or Mass Persuasion for Health?
American Journal of Public Health 1968;58:(1):131–137
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1228049/

HSL1882
Gourley RH.
Teaching the evaluation of drug advertising to medical students.
Va Med Mon 1966 Aug;93:(8):459-61

HSL694
Daniel EE, Leedham L.
Effect on student attitudes of a program of critical evaluation of claims for drugs.
J Med Educ 1966 Jan;41:(1):49-60

HSL2060
Talalay P, Editor.
Drugs in Our Society.
Baltimore: John Hopkins Press 1964
http://www.amazon.com/exec/obidos/tg/detail/-/0801806194/qid=1124494429/sr=1-1/ref=sr_1_1/002-4340062-2313626?v=glance&s=books

HSL9050
Harris R.
The Real Voice
: MacMillan 1964

HSL2280
Diamond S.
Information and Error: An Introduction to Statistical Analysis.
New York: Basic Books 1963

HSL19865
Burkholder D
The Role of the Pharmaceutical Detailman in a large teaching hospital
Americal Journal of Hosiptal Pharmacy 1963;20:275-285

HSL17397
Wharton AB
Postcard advertising of drugs
BMJ 1962 Mar 17;1:(5280):803
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1957927/?page=1

HSL14167
May CD.
Selling drugs by 'educating' physicians.
J Med Educ. 1961 Jan;36:1-23:
http://www.ncbi.nlm.nih.gov/pubmed/13768513

HSL1610
Garb S.
Teaching medical students to evaluate drug advertising.
J Med Educ 1960 Aug;35:(8):729-39

HSL15554
Too Many Drugs?
Time 1960 Apr 25
http://www.time.com/time/magazine/article/0,9171,826313,00.html

HSL2106
Dichter E.
The strategy of desire
New York: Doubleday & Co 1960
http://www.transactionpub.com/cgi-bin/transactionpublishers.storefront/4306a0e2002ffed69c4fc0a80a7306e0/Product/View/0&2D7658&2D0894&2D3

HSL15522
Longstreet VM.
The Effectiveness of Pharmaceutical Promotion
Journal of Marketing 1959 Apr;23:(4):472-472
http://www.marketingpower.com/AboutAMA/Pages/AMA%20Publications/AMA%20Journals/Journal%20of%20Marketing/JournalofMarketing.aspx#1

HSL4707
Festinger L, Carlsmith JM
Cognitive consequences of forced compliance.
J Abnorm Psychol 1959 Mar 01;58:(2):203-10

HSL2276
Popper KR.
The Logic of Scientific Discovery
London: Hutchinson 1959
http://www.amazon.co.uk/exec/obidos/ASIN/0415278449/qid=1124937721/sr=2-2/ref=sr_2_11_2/026-3295786-4558021

HSL1883
Garb S.
The reaction of medical students to drug advertising.
N Engl J Med 1958 Jul 17;259:(3):121-3

HSL14168
Dowling HF.
Twixt the cup and the lip.
J Am Med Assoc. 1957 Oct 12;165:(6):657-61
http://www.ncbi.nlm.nih.gov/pubmed/13462823

HSL2277
Fisher R.
The Design of Experiments
London: Oliver & Boyd 1949
http://www.amazon.co.uk/exec/obidos/search-handle-form/026-3295786-4558021

HSL14520
[No authors listed].
Advertising of medicines; new code of standards.
J Pharm Pharmacol. 1948 Apr 24;106:(4408):291
http://www.ncbi.nlm.nih.gov/pubmed/18916979

HSL695
Beazley RN.
Drug Advertisements
Med J Aust 1935 Jan 12;72

HSL2282
Neyman J, Pearson ES.
On the problem of the most efficient tests of statistical hypotheses
Philos Trans Royal Soc: Ser A 1933;231:289-337

HSL9051
Huxley A.
Brave New World
: Harper Collins 1931
http://www.harpercollins.com/books/9780060850524/Brave_New_World/index.aspx

HSL2041
Hopkins CC.
My Life in Advertising.
Chicago: 1996 reprint by NTC Business Books 1927
http://books.mcgraw-hill.com/getbook.php?isbn=0844231010&template=

HSL2042
Hopkins CC.
Scientific advertising.
Chicago: 1996 reprint by NTC Business Books 1923
http://books.mcgraw-hill.com/getbook.php?isbn=0844231010&template=

HSL9089
Wells HG
Tono-Bungay
New York: Dodd, Mead & Co 1908
http://www.amazon.com/Tono-Bungay-Modern-Library-Classics-Wells/dp/081296750X

HSL16717
Wolfe S
Patients for Sale?
The Washington Post 1897 Oct 4

HSL2052
Bentham J, Dumont P, Bingham P.
Bentham's handbook of political fallacies
Baltimore: John Hopkins Press 1824
http://www.amazon.com/exec/obidos/tg/detail/-/B0006S0DMG/qid=1124494775/sr=1-1/ref=sr_1_1/002-4340062-2313626?v=glance&s=books

HSL693
Locke J.
An essay concerning human understanding
1690
http://etext.library.adelaide.edu.au/l/locke/john/l81u/index.html

HSL692
Aristotle.
Rhetoric.
Date uncertain 350 350 BCE
http://www.public.iastate.edu/~honeyl/Rhetoric/index.html

HSL2677
Canadian Association of Retired Persons
C.A.R.P.’s position on the direct-to-consumer advertising of prescription drugs
Canadian Association of Retired Persons;
www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/consult/wkshd2ca.zip

HSL11089
[No authors listed].
Antidepressants and suicide. The history of a controversy--and where it stands today
Harv Ment Health Lett. 2007 July;24:(1):1-4.
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17663067&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

HSL12554
Time-Line for Forsyth v. Eli Lilly Trial
: Baum Headland Date uncertain
http://www.baumhedlundlaw.com/media/timeline.html

HSL19757
Moynihan R, Cassels A
Selling Sicknes
arena magazine 2005 Dec

HSL16351
Van Duppen D
La guerre des médicaments. Pourquoi sont-ils si chers? Bruxelles: Aden 2005
http://www.chapitre.com/CHAPITRE/fr/BOOK/van-duppen-dirk/la-guerre-des-medicaments-pourquoi-sont-ils-si-chers,1639372.aspx

HSL16352
Welch G
Should I be tested for cancer. Maybe Not and Here’s Why. Berkley and Los Angeles: University of California Press 2004
http://books.google.com.au/books?id=SAXl2PASXNkC&dq=Welch,+Gilbert.+Should+I+be+tested+for+cancer.+Maybe+Not+and+Here’s+Why.&printsec=frontcover&source=bn&hl=en&ei=DrKYSvWeNJODkAWquqyrAg&sa=X&oi=book_result&ct=result&resnum=4#v=onepage&q=&f=false

HSL16353
Young T
Death by Prescription Toronto: Key Porter Books 2009
http://www.amazon.ca/Death-Prescription-Father-Daughters-Killer/dp/1552638251

HSL16381
Moynihan R
Drug Safety: Battle over popular bone drug Fosamax bursts into court
BMJ 2009 08 06;
http://www.bmj.com/cgi/content/extract/339/aug06_1/b3155

HSL16384
Exorcising authors
The Finanical Times 2009 08 30
http://www.ft.com/cms/s/0/f7434ad6-9588-11de-90e0-00144feabdc0.html?nclick_check=1

HSL16393
Bextra Whistleblower Case Started Investigation of Pfizer
Reuters 2009 09 02
http://www.reuters.com/article/pressRelease/idUS158792+02-Sep-2009+PRN20090902

HSL16420
Parsai G
Modify the pill advertisements, Drug Controller asks manufacturers
The Hindu 2009 09 09
http://beta.thehindu.com/news/national/article17177.ece

HSL16454
Williams SJ, Gabe J, Davis P
Pharmaceuticals and Society: Critical Discourses and Debates : Wiley-Blackwell 2009
http://au.wiley.com/WileyCDA/WileyTitle/productCd-1405190841,descCd-description.html

HSL16457
Hutton D
Whistleblowing at Health Canada: Chopra speaks out
CMAJ 2009 09 15;181:(6-7):
http://www.cmaj.ca/cgi/content/full/181/6-7/E121

HSL16472
PharmaTimes Great Oxford Debate - 2009
Pharma Times 2009
http://www.pharmatimes.com/Competitions/Great-Oxford-Debate/2009debate.aspx

HSL19470
Sladek RM, Phillips PA, Bond MJ.
Measurement properties of the Inventory of Cognitive Bias in Medicine (ICBM).
BMC Med Inform Decis Mak 2008 28;8:20:
http://www.biomedcentral.com/1472-6947/8/20

HSL16546
Sawaya L
The Persuasion Report Orleans, Canada: Reticulum 2009
https://cp.experthost.com/ssl/18/reticulum.ca/books_s3.php

HSL16587
Issues and Challenges Related to Local Television: Report of the Standing Committee on Canadian Heritage
: House of Commons, Canada 2009 Jun
http://www2.parl.gc.ca/HousePublications/Publication.aspx?DocId=4005108&Language=E&Mode=1&Parl=40&Ses=2

HSL16592
Krimsky S, Sweet E
An Analysis of Toxicology and Medical Journal Conflict-of-Interest Polices
Accountability in Research 2009;16:(5):235 - 253
http://www.informaworld.com/smpp/content~db=all~content=a914972083

HSL16601
Evaluating evolving sales models & advanced technology for a customer centric approach
Pharmaceutical Sales Force Effectiveness Strategies 2009 Aug
http://www.reportlinker.com/p0148147/Pharmaceutical-Sales-Force-Effectiveness-Strategies-Evaluating-evolving-sales-models--advanced-technology-for-a-customer-centric-approach.html

HSL16644
Drury J, Cocking C, Beale J, Hanson C, Rapley F
The phenomenology of empowerment in collective action
Br J Soc Psychol 2005;44:(3):309-28
http://eprints.sussex.ac.uk/2063/

HSL16656
Anvisa não pode regulamentar publicidade, diz juiz
Consultor Jurídico 2009 10 23
http://www.conjur.com.br/2009-out-23/anvisa-nao-competencia-regulamentar-publicidade-juiz

HSL16678
Perrone M
GAO: FDA fails to follow up on unproven drugs
Yahoo News 2009 10 26
http://news.yahoo.com/s/ap/20091026/ap_on_he_me/us_fda_unproven_drugs

HSL16679
FDA Needs to Enhance Its Oversight of Drugs Approved on the Basis of Surrogate Endpoints
United States Government Accountability Office 2009 Sep
http://www.gao.gov/new.items/d09866.pdf

HSL16697
Wolfe S
Feminine Straight to the Grave
Mother Jones 1978 May18‑19

HSL16698
Wolfe S
The New Drop Dead Diet.
Mother Jones 1978 Jun

HSL16699
Wolfe S
What Your Doctor Hides from You.
Mother Jones 1978 Aug11‑12

HSL16996
Dunn A
Best Strategic Learning Investment in 2010?
Hoenig Carlson E Courtney Justice, The Cournell Group 2009 Dec
http://docs.google.com/fileview?id=0B2pN9F6nMK5MZjQ2MjEyYjMtNzc5Yi00NjVjLWIwZmItYTI1NDZlZTk2NDgw&hl=en

HSL17335
Baucus M, Grassley C
Staff Report on GlaxoSmithKline and The Diabetes Drug Avandia
Committee on Finanace United States Senate 2010 Jan
http://www.cafepharma.com/boards/showthread.php?t=412204

HSL17400
Haag D
rapport in het kader van algemeen toezicht naar aanleiding van het onderzoek bij Sanofi Pasteur MSD naar het geneesmiddel Gardasil (Report about Sanofi)
Staatstoezicht Op De Volksgezondheid 2009 July
http://www.spmsd.nl/143608/Rapport-inspectie-nav-WOB-verzoek.pdf

HSL17401
Haag D
Rapport in het kader van algemeen toezicht naar annleiding van het onderzoek bij GSK naar geneesmiddel Cervarix
Staatstoezicht Op De Volksgezondheid 2009 July
http://www.gsk.nl/downloads/files/rapportonderoekbijGSKnaargeneesmiddelCervarix.pdf

HSL19057
Schwartz LM, Woloshin S.
Changing disease definitions: implications for disease prevalence. Analysis of the Third National Health and Nutrition Examination Survey, 1988-1994.
Eff Clin Pract 1999;2:(2):76-85.
http://www.acponline.org/clinical_information/journals_publications/ecp/marapr99/changing.htm

HSL19082
Otra vez la Menopausia
No Gracias 2011
http://www.noticiascanarias.com/index2.php?option=com_content&do_pdf=1&id=41544

HSL19083
El dilema de las Guías Clínicas
No Gracias 2011
http://www.nogracias.eu/v_portal/informacion/informacionver.asp?cod=7639&te=&idage=&vap=0&codrel=642

HSL19091
Kersnik J, Klemenc-Ketis Z, Petek-Ster M, Tusek-Bunc K, Poplas-Susic T, Kolsek M.
Family doctors' views of pharmaceutical sales representatives: assessment scale development.
Fam Pract 2011 2;
http://fampra.oxfordjournals.org/content/early/2011/02/02/fampra.cmq105.long

HSL19092
Ladd EC, Mahoney DF, Emani S.
'Under the radar': nurse practitioner prescribers and pharmaceutical industry promotions.
Am J Manag Care 2010 1;16:(12):e358-62
http://www.ajmc.com/issue/managed-care/2010/2010-12-vol16-n12/AJMC_10decLadd_WebX_e358to62

HSL19094
Tanne JH.
'Inverse benefit law' explains how drug marketing undermines patient safety.
BMJ 2011 28;342:d598: doi: 10.1136/bmj.d598. No abstract available.
http://www.bmj.com/content/342/bmj.d598.long

HSL19129
Sales Through Retail Pharmacies (Twelve months to November 2010)
ims 2011 Jan
http://view.respond.imshealth.com/?j=fe54157876630d7e7c17&m=fef31377726304&ls=fdfa17757666017475127374&l=fe9615727662037d73&s=fe21127975600c75701171&jb=ffcf14&ju=fe1c1671726d0c7b771d77&r=0

HSL19401
Brody H.
Responses to peer commentaries on 'Clarifying conflict of interest'
Am J Bioeth 2011;11:(1):W4-5
www.ncbi.nlm.nih.gov/pubmed/21240796

HSL19397
Ching A, Ishihara M
The effects of detailing on prescribing decisions under two-sided learning
Tortonto: University of Toronto 2007
http://mpra.ub.uni-muenchen.de/4935/

HSL19324
Lexchin J.
Those Who Have the Gold Make the Evidence: How the Pharmaceutical Industry Biases the Outcomes of Clinical Trials of Medications.
Sci Eng Ethics 2011 15;
http://www.springerlink.com/content/k3306qh046375277/

HSL19331
Majumdar SR, McAlister FA, Soumerai SB.
Synergy between publication and promotion: comparing adoption of new evidence in Canada and the United States.
Am J Med 2003 15;115:(6):467-72
http://www.ncbi.nlm.nih.gov/pubmed/14567371

HSL19165
Herzberg D.
'Will wonder drugs never cease!': a prehistory of direct-to-consumer advertising.
Pharm Hist 2009;51:(2):47-56
http://www.ncbi.nlm.nih.gov/pubmed/20853552

HSL19166
Karlowicz KA.
Direct-to-consumer advertising for erectile dysfunction drugs.
Urol Nurs 2009;29:(4):214
http://www.ncbi.nlm.nih.gov/pubmed/19718935

HSL19167
Stell LK.
Drug reps off campus! Promoting professional purity by suppressing commercial speech.
J Law Med Ethics 2009;37:(3):431-43,
http://onlinelibrary.wiley.com/doi/10.1111/j.1748-720X.2009.00404.x/abstract

HSL19168
Tamimi NA, Ellis P.
Drug development: from concept to marketing!
Nephron Clin Pract. 2009;113:(3):c125-31
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=000232592

HSL19185
Vance MA.
Disease mongering and the fear of pandemic influenza.
Int J Health Serv 2011;41:(1):95-115
http://www.ncbi.nlm.nih.gov/pubmed/21319723

HSL19186
Rusert BM, Royal CD.
Grassroots Marketing in a Global Era: More Lessons from BiDil.
J Law Med Ethics 2011;39:(1):79-90 doi: 10.1111/j.1748-720X.2011.00552.x.
http://onlinelibrary.wiley.com/doi/10.1111/j.1748-720X.2011.00552.x/abstract

HSL19187
Davis C, Abraham J.
Desperately seeking cancer drugs: explaining the emergence and outcomes of accelerated pharmaceutical regulation.
Sociol Health Illn 2011 11; doi: 10.1111/j.1467-9566.2010.01310.x. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/21314687

HSL19247
Iskowitz M
CME providers must correct violative info, council says
Medical Marketing & Media 2010 12 23
http://www.mmm-online.com/cme-providers-must-correct-violative-info-council-says/article/193301/

HSL19249
Arnold M
Online groups are hotbed of promotion
Medical Marketing & Media 2010 11 15
http://www.mmm-online.com/online-groups-are-hotbed-of-promotion/article/191743/

HSL19382
Canli H, Saatci E, Bozdemir N, Akpinar E, Kiroglu M.
The antibiotic prescribing behaviourof physicians for acute tonsillopharyngitis in primary care.
Ethiop Med J 2006;44:(2):139-43
http://www.ncbi.nlm.nih.gov/pubmed/17447376

HSL19383
Charbit O
[Influence de la publicité pharmaceutique sur la prescription.] Influence of pharmaceutical advertising on prescription
MD Dissertation Toulouse: University Paul Sabatier Toulouse III. 2003

HSL19384
Freemantle N, Johnson R, Dennis J, Kennedy A, Marchment M
Sleeping with the enemy? A randomized controlled trial of a collaborative health authority/industry intervention to influence prescribing practice.
Medicines Evaluation Group 2000;49:(2):174-9
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2014899/?tool=pubmed

HSL19374
Rothman DJ, McDonald WJ, Berkowitz CD, Chimonas SC, DeAngelis CD, Hale RW, Nissen SE, Osborn JE, Scully JH Jr, Thomson GE, Wofsy D.
Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest.
JAMA 2009 1;301:(13):1367-72
http://jama.ama-assn.org/content/301/13/1367.long

HSL19372
Garai P
Advertising and promotion of drugs
Talalay P Drugs in our society. Baltimore: John Hopkins Press 19640

HSL19370
Steen RG.
Retractions in the scientific literature: do authors deliberately commit research fraud?
J Med Ethics 2011;37:(2):113-7
http://jme.bmj.com/content/37/2/113.long

HSL19631
Qureshi ZP, Sartor O, Xirasagar S, Liu Y, Bennett CL.
Pharmaceutical fraud and abuse in the United States, 1996-2010.
Arch Intern Med 2011 12;171:(16):1503-6
http://archinte.ama-assn.org/cgi/content/full/171/16/1503

HSL19644
Corporate Voices Toolkit Ilustrates Perils of Conflicts of Interest
banthebags.org 2011 May
http://banthebags.org/347

HSL19652
Henrique Prezzi S
Drotrecogina na Sepse - Contraponto
2007 Aug
http://www.medicinahospitalar.com.br/Aulas/ContrapontoDotrecogina/Drotrecogina_files/intro.htm

Page 203 of 206 pages ‹ First  < 201 202 203 204 205 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.







Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909